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Abstract
GB virus B (GBV-B) is closely related to hepatitis C virus (HCV), infects small non-human primates, and is thus a valuable
surrogate for studying HCV. Despite significant differences, the 59 nontranslated RNAs (NTRs) of these viruses fold into four
similar structured domains (I-IV), with domains II-III-IV comprising the viral internal ribosomal entry site (IRES). We previously
reported the in vivo rescue of a chimeric GBV-B (vGB/III
HC) containing HCV sequence in domain III, an essential segment of the
IRES. We show here that three mutations identified within the vGB/III
HC genome (within the 39NTR, upstream of the poly(U)
tract, and NS5A coding sequence) are necessary and sufficient for production of this chimeric virus following intrahepatic
inoculation of synthetic RNA in tamarins, and thus apparently compensate for the presence of HCV sequence in domain III. To
assess the mechanism(s) underlying these compensatory mutations, and to determine whether 59NTR subdomains
participating in genome replication do so in a virus-specific fashion, we constructed and evaluated a series of chimeric
subgenomic GBV-B replicons in which various 59NTR subdomains were substituted with their HCV homologs. Domains I and
II of the GBV-B 59NTR could not be replaced with HCV sequence, indicating that they contain essential, virus-specific RNA
replication elements. In contrast, domain III could be swapped with minimal loss of genome replication capacity in cell
culture. The 39NTR and NS5A mutations required for rescue of the related chimeric virus in vivo had no effect on replication of
the subgenomic GBneoD/III
HC RNA in vitro. The data suggest that in vivo fitness of the domain III chimeric virus is dependent
on a cooperative interaction between the 59NTR, 39NTR and NS5A at a step in the viral life cycle subsequent to genome
replication, most likely during particle assembly. Such a mechanism may be common to all hepaciviruses.
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Introduction
Hepatitis C virus (HCV) infection is an important public health
concern with about 170 million persons chronically infected
worldwide who are at risk for developing liver cirrhosis and
hepatocellular carcinoma. To date, the only available treatment is
a combination therapy with pegylated interferon-a and ribavirin,
which remains poorly effective for HCV genotype 1 infections, and is
generally difficult to tolerate, leading to $50% therapeutic failures
[reviewed in Ref. 1]. The development of specific, small molecule
antiviral inhibitors that could be used to cure this infection is thus
currently a high priority. Immunocompetent animal models
susceptible to HCV infection would be useful to support these efforts
andmonitorpotentialantiviralresistancemechanisms.Asasurrogate
for chimpanzees,which represent the onlyimmunocompetent animal
model for human HCV infection but which are endangered and
extraordinarily difficult to access, infection of small New World non-
human primates from the Callithrichidae family (tamarins, marmosets)
with a closely related, hepatotropic virus, GB virus B (GBV-B), may
prove useful [2,3]. In most cases, experimental infection of tamarins
or marmosets with GBV-B induces an acute hepatitis [2,4], but in
limited cases described to date, experimental GBV-B infection has
alsoresulted in an extended viremia and chronic hepatitis in tamarins
[5,6], mimicking closely chronic hepatitis C in humans.
GBV-B is an enveloped virus that belongs to the Flaviviridae
family, and has tentatively been classified within the same genus as
PLoS ONE | www.plosone.org 1 February 2009 | Volume 4 | Issue 2 | e4419HCV, the hepacivirus genus [7]. We and others have shown that
GBV-B shares a number of features with HCV, but also exhibits
some differences, in terms of genomic organization [8,9], viral
protein maturation [10–12], and virus/host interactions [13–16].
The GBV-B genome contains a single open reading frame
encoding a polyprotein which is subsequently cleaved into three
structural proteins and seven nonstructural (NS) proteins, among
which NS3 to NS5B, only, are required for efficient genome
replication in cell culture [17]. The GBV-B and HCV 59 and 39
nontranslated RNA (NTR) segments share structural similarities
despite significantly divergent nucleotide sequences and lengths.
GBV-B and HCV 59NTRs (445 and 341 nucleotides in length,
respectively) are each predicted to fold into four structural
domains composed of one or several stem-loops (I, II, III and
IV, see Fig. 1A) [18,19]. Like HCV and pestivirus 59NTRs, the
GBV-B 59NTR contains an internal ribosomal entry site (IRES)
which drives the initiation of cap-independent RNA translation by
specific binding of the 40S ribosomal subunit [19,20]. GBV-B and
HCV structural domains II, III and domain IV, extending up to
the initiating AUG codon are essential for IRES activity [19,21],
while the first ,40 nucleotides of the downstream core coding
segment may modulate IRES function [22–24]. HCV 59NTR
domains I and II have also been shown to both contain essential
RNA replication elements, while domain III is not essential, but
substantially upregulates HCV RNA replication [25–27]. At the
other end of the genome, the HCV 39NTR is composed of a short
variable region, followed by a poly(U/UC) tract with 80
nucleotides on average and an almost invariant 98 nucleotide
long sequence, the 39X region. The GBV-B 39NTR has a similar
overall organization, although with a shorter and homopolymeric
poly(U) sequence in lieu of the poly(U/UC) tract in HCV, and a
larger sequence downstream of the poly(U) stretch comprising 309
nucleotides. The HCV 39X region, as well as a minimal poly(U/
UC) sequence are known to be essential elements required for
genome replication [28,29]. In contrast, the analysis of GBV-B
genome replication elements has been hampered by the lack of
suitable cell culture models in which this can be studied.
We previously reported that the substitution of domains II-III or
I-II-III within the 59 NTR segment of an infectious molecular
clone of GBV-B with the homologous sequences from HCV had a
lethal effect on viral replication, preventing the rescue of infectious
virus following intrahepatic inoculation of synthetic RNA into
tamarins [3]. In contrast, intrahepatic inoculation of a full-length
chimeric GBV-B RNA in which only domain III was substituted
with its HCV counterpart resulted in the rescue of a chimeric virus
(vGB/III
HC) in tamarins. The genome of the chimeric virus
recovered from serum of infected tamarins was found to contain 6
stable nucleotide substitutions, all outside of the chimeric 59NTR
sequence [3]. In the present study, we have analyzed these
mutations and show that 3 of the 6 mutations (in the 39NTR and
NS5A coding sequence) are both necessary and sufficient for a
robust, wild-type-like viral replication phenotype in vivo, and thus
presumably compensate for a reduction in replication fitness
imposed by the chimeric HCV sequences within domain III of the
59NTR. To assess the mechanism(s) underlying these compensa-
tory mutations, we have evaluated a series of chimeric RNAs
derived from a subgenomic GBV-B replicon which autonomously
replicates in human hepatoma cells [30]. We show that domains I
and II of the GBV-B 59NTR contain essential and virus-specific
RNA replication signals, whereas domain III, which is essential for
virus translation, does not play a critical, virus-specific role in RNA
replication. The substitution of domain III in the GBV-B replicon
with the corresponding HCV domain resulted in a replication-
competent chimeric RNA with only moderately decreased
replication capacity in cell culture. We show that the 39NTR
and NS5A substitutions required for robust replication of the
corresponding 59NTR chimeric virus in vivo are not required for,
nor modulate the RNA replication capacity of the chimeric
replicon. These data suggest the existence of a cooperative
interaction between the hepacivirus 59 and 39 NTRs and NS5A
that is essential for a step in the virus life cycle subsequent to
genome replication, most likely particle assembly.
Figure 1. Chimeric GBV-B/HCV replicons engineered. (A) The
predicted schematic secondary structures of domains I-IV, each
highlighted by shaded areas, in 59NTRs of GBV-B (left) and HCV (right)
are shown. Subdomains forming stem-loops are labeled. Base-pair
interactions within an RNA pseudo-knot at the base of domain III are
indicated by dotted lines. Core coding sequences downstream of the
initiator AUG codon in domain IV are represented by thick lines. (B) The
parental GBV-B subgenomic replicon cDNA, neo-RepD [30], cloned
downstream of the T7 RNA polymerase promoter is schematically
represented at the top of the panel. The first cistron downstream of the
GBV-B 59NTR encodes a fusion polypeptide comprised of the 22 N-
terminal core amino acids (DC) and neomycine phosphotransferase
(Neo
R), while the second cistron encodes GBV-B nonstructural proteins
NS3-NS5B downstream of the murine encephalomyocarditis virus
(EMCV) IRES. In the blow up of the 59NTR, boundaries of domains I, II,
III, IV are indicated with the position of the translation AUG initiator
codon. For each chimeric 59NTR, GBV-B and HCV sequences are
represented by white and black boxes, respectively, that are drawn to
scale according to nucleotide lengths of each domain. Dotted lines
indicate shorter domains in one viral 59NTR with respect to
counterparts in the other virus. Arrows below domain schemes
delineate IRES sequences.
doi:10.1371/journal.pone.0004419.g001
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Mapping RNA replication signals in the GBV-B 59NTR
using chimeric GBV-B/HCV replicons
We previously reported that chimeric, genome-length GBV-B
RNAs in which domains I-II-III or II-III of the 59NTR were
substituted by corresponding domains of HCV 59NTR were not
infectious upon intrahepatic inoculation of synthetic RNAs in
tamarins [3]. To assess whether this lack of infectivity was due to an
RNA replication defect,ora defectinsomeother stepinthe viruslife
cycle, we replaced the different structural domains of GBV-B
59NTR (Fig. 1A) with the corresponding domains of the H77 strain
of genotype 1a HCV [31] within the backbone of a dicistronic,
subgenomic GBV-Breplicon[neo-RepD,Ref.30].In the GBneoD/
I-III
HC replicon, the nearly entire GBV-B 59NTR (domains I-II-III)
was substituted with HCV domains I-II-III. GBneoD/II-III
HC
contains sequences comprising most of the HCV IRES (domains II-
III) in place of the corresponding GBV-B domains downstream of
GBV-B domainI.GBneoD/III
HCcontains onlydomainIIIofHCV
in place of the corresponding GBV-B domain downstream of GBV-
B domains I-II ; hence, it harbors a chimeric IRES (Fig. 1B). The
domain IV sequence comprising 14 nucleotides up to the AUG
initiator codon, that modulates IRES activity [24], was derived from
GBV-B in all three constructs. These chimeric GBV-B/HCV
59NTRs thus correspond to those analyzed in the genome-length
chimeric RNAs tested previously for viability in intrahepatically-
inoculated tamarins [3].
59NTR sequences may be involved in both RNA replication and
translation, and thus the HCV 59NTR sequences in these chimeric
replicons may be required to functionally substitute for GBV-B
sequences in providing critical replication signals. However, a defect
in RNA replication could theoretically be masked by inefficiencies in
translation imposed by the chimeric 59NTR segments. Therefore, to
determinethe minimalvirus-specific 59NTR sequences necessaryfor
GBV-B RNA replication, we constructedGBV-B/HCVchimeras in
which translation was placed under the control of an intact HCV
IRES, while segments of GBV-B 59NTR potentially involved in
genomereplication (domains I-II or I-II-III)were retained upstream.
These constructs were thus generated with the aim of uncoupling
replication from translation signals contained within the GBV-B
59NTR.TheHCV IRESwaseithernearlycomplete(domainsII-III,
with domain IV derived from GBV-B, in GBneoD-I-II
GB/II-III
HC),
or intact (domains II-III-IV, in GBneoD-I-II
GB/II-IV
HC and
GBneoD-I-III
GB/II-IV
HC) in these constructs (Fig. 1B). To avoid
potential steric hindrance and functional interference between the
highly structured GBV-B and HCV domains, a 23-nucleotide-long
spacer was inserted upstream of the HCV IRES (see Material and
Methods).
The translational activities of the chimeric GBV-B/HCV
replicon 59NTRs were first monitored in rabbit reticulocyte
lysates, in the presence of microsomal membranes such as to
optimize the processing of the viral nonstructural polyprotein
NS3-NS5B synthesized from the second cistron of the replicons
[32]. GBV-B/HCV IRESs present in the chimeric replicons drive
the synthesis of either of two fusion polypeptides consisting of 22
GBV-B core codons (when domain IV is derived from GBV-B) or
12 HCV core codons (when domain IV is derived from HCV)
fused to neomycin phosphotransferase (DC-neo) (see Fig. 1B). A
typical electrophoresis pattern of in vitro translated NS3 and DC-
neo polypeptides, as well as quantitation of DC-neo products
normalized with respect to the synthesis of NS3 (produced from
the second cistron under translational control of the EMCV IRES)
in replicate experiments are shown in Fig. 2A. Normalization with
respect to another cleavage product from the second cistron
(NS4B) gave similar values (not shown). These data demonstrated
that the in vitro translational efficiencies of the different chimeric
59NTRs with domain swaps (GBneoD/I-III
HC, GBneoD/II-
III
HC, GBneoD/III
HC) were equivalent to or higher than that of
the parental neo-RepD. The translational activities of these
chimeric replicon RNAs were thus in good agreement with data
previously obtained for similar chimeric 59NTRs driving the
synthesis of a reporter protein (renilla luciferase) encoded by
monocistronic transcripts [3]. Replicons in which replication and
translation activities were uncoupled (GBneoD-I-II
GB/II-III
HC,
GBneoD-I-II
GB/II-IV
HC, GBneoD-I-III
GB/II-IV
HC) also demon-
strated translational competence, although with decreased effi-
ciency compared to chimeras in which domains II-III were
swapped, in particular for GBneoD-I-II
GB/II-III
HC (Fig. 2A). This
could possibly be due to partial (GBneoD-I-II
GB/II-III
HC,
GBneoD-I-II
GB/II-IV
HC) or complete (GBneoD-I-III
GB/II-IV
HC)
redundancy of GBV-B and HCV IRES elements that may
compete for the binding of translational factors.
Since cellular factors may modulate chimeric GBV-B/HCV
RNA translation, we next assayed translational efficiencies of the
various chimeric 59NTRs in cell culture. For that purpose, GBV-B
permissive cells, derived from the Huh7 human hepatoma cell line
[cB76.1/Huh7 cells, Ref. 17] were transfected with chimeric
replicons encoding firefly luciferase (F-Luc) as a reporter protein in
place of neomycin phosphotransferase (Fig. 2B). Quantification of
F-Luc at 4 hours post-transfection, normalized with respect to
total protein quantities, reflected translational activities of input
RNAs prior to the onset of RNA replication. Relative luciferase
activities were in the same range for all five chimeric replicons
tested, as well as the parental GBV-B F-Luc replicon and a
replication-incompetent GBV-B F-Luc RNA mutant harboring
mutations in the sequence encoding the RNA polymerase active
site (LucD-GAA) (Fig. 2B). As expected, a control GBV-B replicon
RNA lacking 59NTR domain III (Luc-RepDDIII) produced
background levels of luciferase activity (Fig. 2B). It is worth noting
that the translational activity of GBneoD-I-II
GB/II-III
HC was
slightly reduced (67–79%), as compared to the parental neo-RepD
and chimeric GBneoD-I-II
GB/II-IV
HC levels, both in vitro (Fig. 2A)
and in cells (Fig. 2B), highlighting the contribution of homologous
domain IV to HCV IRES activity. Altogether, these results show
that the various chimeric 59NTRs retain translational competence
in Huh7 cells with no marked differences in efficiency.
To analyze their replication capacity, the chimeric GBV-B/HCV
RNA transcripts were transfected into cB76.1/Huh7 cells and cells
were maintained under G418 selective pressure for 3 weeks. No
replicon containing G418-resistant cell clone was observed after
transfection of the GBneoD/I-III
HC or GBneoD/II-III
HC RNA
(data not shown). These results thus show that the substitution of
domainsI-II-III orII-IIIof GBV-B by corresponding HCV domains
within the backbone of a GBV-B subgenomic replicon abrogates
RNA replication in cell culture, while RNA translation was
unaffected (Fig. 2). These results also indicate that the lack of
infectivity of genome-length RNAs with similar chimeric 59NTRs
followingintrahepaticinoculationintamarins,asreportedpreviously
[3], was due to a major defect in RNA replication. In sharp contrast,
numerous G418-resistant cell clones were obtained following
transfection of the GBneoD/III
HC RNA, although approximately
7-fold less, compared to the parental GBV-B replicon neo-RepD
(Fig. 3A). This moderately reduced replication capacity cannot be
attributed to a translational defect of the chimeric 59NTR (Fig. 2).
Eight cell clones were isolated and expanded from GBneoD/III
HC
transfections and viral RNAs present in these clones were analyzed
by real-time quantitative RT-PCR. GBneoD/III
HC RNA was
detected in all clones with an abundance (6.1160.17 log genome
GBV-B Replication Elements
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containing the parental neo-RepD RNA (5.8860.03). The integrity
of GBneoD/III
HC RNAs present in cell clones was verified by
Northern blot detection of viral RNA after electrophoresis on
denaturing gels (Fig 3B). Viral RNA extracted from 5 cell clones was
reverse-transcribed, PCR-amplified and sequenced in its entirety,
with the exception of the 40 59 and 100 39 terminal nucleotides,
respectively. In all cases, the chimeric nature of the 59NTR was
confirmed and no mutation was found from the initial chimeric
replicon sequence (data not shown). These data indicate that the
substitution of domain III resulted in a replication-competent
chimeric replicon, although with moderately decreased (,7-fold
lower) colony forming efficiency compared to neo-RepD. This
supports the infectivity of a genome-length GBV-B chimera
harboring a similar domain III substitution, as observed upon
intrahepatic inoculation of synthetic RNA [3].
To further investigate whether only domains I-II of GBV-B
contain critical, virus-specific RNA replication elements, we
similarly analyzed the chimeric replicons in which translation
was uncoupled from replication and no longer dependent on the
GBV-B 59NTR. As shown in Fig. 3A, the number of G418-
resistant cell clones obtained after transfection of cB76.1/Huh7
cells with GBneoD-I-II
GB/II-III
HC or GBneoD-I-II
GB/II-IV
HC
replicon was in the same range as that obtained with neo-RepD.
Colony formation was ,2.5-fold less efficient with GBneoD-I-
II
GB/II-III
HC than with GBneoD-I-II
GB/II-IV
HC (Fig. 3A), which
might be correlated with decreased translational activity (Fig. 2B).
Previous studies of HCV replicons in which translation was placed
under the control of poliovirus IRES, with various lengths of 59-
terminal HCV sequences were retained upstream, indicated that
the 59NTR domain III in HCV contains important replication
signals that substantially enhance RNA replication [25,26]. To
determine whether sequences within GBV-B domain III could also
modulate RNA replication, we assessed the colony forming
efficiency of GBneoD-I-III
GB/II-IV
HC, which differs from
GBneoD-I-II
GB/II-IV
HC by the addition of GBV-B domain III
upstream of the HCV IRES. As shown in Fig. 3A, the number of
cell clones obtained with GBneoD-I-III
GB/II-IV
HC replicon did
not significantly differ from that obtained with GBneoD-I-II
GB/II-
IV
HC. Sequences of chimeric replicon RNAs recovered from pools
of G418-resistant cell clones at 3 weeks post-transfection were
shown to correspond to input sequences in noncoding regions,
indicating that partially duplicated 59NTRs were not rearranged
upon RNA replication. Taken together, these results suggest that
domains I and II of the GBV-B 59NTR, but not domain III,
contain essential, virus-specific RNA replication elements.
Analysis of second site mutations found in the genome
of a domain III chimeric virus rescued in vivo:
compensatory effect on chimeric genome infectivity in
vivo
In previous studies, we found that replacing domain III in an
infectious molecular clone of GBV-B with the corresponding HCV
domain(GB/III
HC) resulted in an infectious genome with rescue of a
chimeric virus following intrahepatic inoculation of RNAs into a
susceptible tamarin, yet with an unusual delay in the onset of
viremia. The rescued virus (vGB/III
HC) was subsequently shown to
give rise to rapid and robust viremia upon passage into a naı ¨ve
animal, and to contain six stable nucleotide substitutions when
compared to the input chimeric RNA [3]. Thus, given the lengthy
Figure 2. Translational activities of chimeric GBV-B/HCV replicon RNAs. (A) Chimeric replicon RNAs (see Fig. 1) and parental GBV-B replicon
RNA neo-RepD were translated in vitro in rabbit reticulocyte lysates. A representative PAGE-SDS pattern of the first cistron products, i.e. fusion
polypeptides between N-terminal core residues and neomycine phosphotransferase (DC-neo, open arrowhead), and of second cistron cleavage
products for normalization purposes (GBV-B NS3, filled arrowhead), is shown. Note that DC-neo polypeptides have different electrophoretic mobilities
depending on the number and nature of N-terminal core residues fused to neo (see text). Translational activities of chimeric replicon RNAs are
represented as mean6SD relative PhosphorImager volumes for DC-neo products quantified from quadruplicate PAGE-SDS gels and normalized with
respect to corresponding NS3 PhosphorImager volumes, expressed relatively to neo-RepD volumes set at 100% (Table). (B) A scheme of the reporter
replicons used to monitor translational activities in cells is shown at the top of the panel. The product encoded by the first cistron of this replicon isa
fusion protein between N-terminal core residues and firefly luciferase (F-Luc). Control reporter RNAs include a translation-deficient GBV-B F-Luc RNA
lacking 59NTR domain III (Luc-RepDDIII) and a replication-deficient GBV-B F-Luc RNA with a mutation in the RNA polymerase active site (LucD-GAA).
Equal amounts (5 mg) of replicon RNAs were transfected into cB76.1/Huh7 cells. Relative F-Luc activities determined at 4 h post-transfection were
expressed after normalization with respect to total protein quantities assayed and relatively to values obtained for parental Luc-RepD, set at 100%.
Shown are means6SD of four independent transfections, each monitored in duplicate wells.
doi:10.1371/journal.pone.0004419.g002
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intrahepatic inoculation of RNA, it is likely that these mutations
compensate for an incompatibility between the HCV domain III
sequence and the GBV-B sequence comprising the balance of
chimeric genome. These mutations include two substitutions leading
to amino acid changes in the p13 and NS5A coding sequences
(U2376C: Ile644Thr; and U7152C: Val2236Ala, respectively), two
substitutions in the 39NTR segment located upstream of the poly(U)
sequence (C9052U, and C9065U), and two silent changes in the E1
and NS5B coding sequences (G1012A, A7945G, respectively)
(numbering refers to nucleotide position within genome-length
GBV-B RNA, see Table 1) [3].
To determine which of these mutations were able to
compensate for the putative defect in the chimeric GBV-B/
HCV genome, we introduced either one or a combination of these
nucleotide substitutions into the chimeric GB/III
HC genome and
assessed the infectivity of each corresponding synthetic RNA by
intrahepatic inoculation into a GBV-B-naı ¨ve tamarin (Fig. 4). In
some cases, we also tested infectivity in a second tamarin, using
animals that had previously received a nonreplicating GBV-B-
derived construct to minimize the number of naı ¨ve animals used in
these studies. We first demonstrated that the inclusion of all 6
nucleotide changes was able to confer an immediate, robust in vivo
replication phenotype to the chimeric RNA (tamarin T16453,
Fig. 4B), similar to the pattern observed after inoculation of the
parental, wild-type GBV-B RNA (T16454, Fig. 4A). A combina-
tion of the two non-silent nucleotide substitutions in p13 and
NS5A, respectively, together with the two 39NTR substitutions
also conferred a robust replication phenotype to the chimeric
genome (T16452, Fig. 4C). This strongly suggests that the two
silent changes in E1 and NS5B coding sequences are not required
for a high level of replication fitness of the chimeric virus.
In other studies, we have found that the NS5A change was
consistently selected for in all viruses rescued in vivo from the wild-
type GBV-B molecular clone used here [3,5], therefore we
hypothesized that this mutation was not directly compensating for
a sequence incompatibility within the chimeric genome. Indeed, the
inclusion of this single substitution did not enhance the infectivity of
the GB/III
HC chimeric genome in two animals tested (T16448 and
T16468, Fig. 4D). Unlike the NS5A mutation, the two 39NTR
mutations have never been observed in viruses rescued in vivo from
the wild-type molecular clone, suggesting they may be in fact true
compensatory mutations. When introduced together in the absence
of the other mutations, the 39NTR mutations were not fully
compensatory, but they did confer a low level of replication, with
sporadic detection of viremia (#2.5610
4 ge/mL) at multiple time
points, (T16457 and T16463, Fig. 4E). However, there was no
further adaptation of the virus before the animals cleared the virus.
The titer of virus in these animal sera were not sufficient to allow
viral genome sequencing. Finally, inclusion of the two 39NTR
mutations, together with the NS5A substitution, fully compensated
for the replication defect introduced by the chimeric 59NTR and
resulted in a parental-type virus replication profile in two tamarins
(compare T16440 and T16459, Fig. 4F, with T16454, Fig. 4A). We
conclude from these studies that the combination of the 39NTR and
NS5A substitutions is both necessary and sufficient for robust
replication of the chimeric virus, but that (as described above) the
NS5A substitution is likely to confer a general increase in replication
fitness independent of the presence or absence of HCV sequence
within the 59NTR (Table 1).
The genomes of viruses recovered at different time points from
tamarins T16440, T16459, T16452, T16453 were sequenced in
regions of interest(59NTR;p13,NS4A and NS5A coding sequences;
39NTR). The chimeric nature of the 59NTR and the presence of
engineered substitutions were confirmed in all cases. Nucleotide
U2376 in the p13 coding sequence that was found mutated towards a
C in the genome of vGB/III
HC was not mutated in the genomes of
T16440 and T16459 viruses at any time point (not shown). This
confirms that the U2376C substitution encoding an Ile644Thr amino
acid change in p13 is not required for adaptation of the chimera to
efficient replication in vivo. The mutated NS5A coding sequence did
not evolve further in any virus (not shown). Interestingly, we
Figure 3. Replication activities of chimeric GBV-B/HCV replicon
RNAs. (A) G418-resistant colony forming activities of the indicated
chimeric replicons (black bars, see Fig. 1) are expressed as means6SD of
log values obtained in $4 independent transfections (2610
6 cells
transfected with 5 mg RNA) performed with $3 independent RNA
transcript syntheses, relatively to that of parental GBV-B replicon (grey
bar) set at the mean value6SD obtained throughout transfection
experiments. Typical patterns of G418-resistant cell clones stained at
3 weeks post-transfection from 100-mm dishes in which 3610
4
transfected cells were plated are shown above the graph. (B) Total
RNA was extracted from 2–3 cell clones individually picked and
expanded after transfection with chimeric replicon GBneoD/III
HC (see
Fig. 1) or parental GBV-B replicon neo-RepD and analyzed by Northern
blot with a riboprobe specific for GBV-B positive-strand RNA after
electrophoresis on a denaturing agarose gel. As controls, RNA from
mock-transfected cells (mock), as well as various quantities of neo-RepD
synthetic RNA transcripts (10
6,1 0
7,1 0
8 genome equivalents) mixed with
cellular RNA from mock-transfected cells, were loaded on the same gel
and processed in parallel. Viral RNA and housekeeping b-actin mRNA,
detected by a specific riboprobe as a loading control, are indicated by
filled and open arrowheads, respectively. Dotted lines indicate where
noncontiguous lanes that belong to the same Northern blot image
have been brought together.
doi:10.1371/journal.pone.0004419.g003
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residues at the 59 end of HCV domain III in virus recovered from
T16440 at early time points (week 4 post-inoculation (p.i.)), and in
virus from T16453 at later time points (week 8 p.i.) (Table 1). A
potentially beneficial effect of this mutation on virus fitness is
suggested by the fact that it was also identified in the original vGB/
III
HC recovered at late time points from the RNA-inoculated animal
(data not shown), although it was not selected for in other chimeric
viruses that replicated efficiently in vivo (T16452 and T16459 viruses)
(Table 1). No mutations were identified in the 39NTR sequence
upstream of the poly(U) tract in chimeric viruses, except in T16453
virusrecoveredatlatetimepoints($week8p.i),inwhichtherewasa
mixture of A (wild-type-like) and G (mutated) residues at nucleotide
9035 (not shown). This mutation has not been found in the genome
of wild-type GBV-B recovered from 5 RNA-inoculated tamarins,
and thus its significance is unknown. Interestingly, a C5226U
nucleotide substitution encoding an Ala1594Val mutation in NS4A
was identified in T16440 virus, while a G5225A substitution encoding
an Ala1594Thr mutation at the same position was observed in
T16452 and T16453 viruses recovered at late time points. No
change in NS4A coding sequence was observed in T16459 virus
(Table 1). Similar changes at this NS4A residue have been observed
in viruses recovered from animals inoculated with wild-type GBV-B
RNA transcripts (viruses from 2 tamarins had an Ala/Val change,
virusesfrom 2 other animalshadan Ala/Thrchange,and virusfrom
1 animal had no change, data not shown). Thus these mutations, like
the U7152C substitution in NS5A, are likely to reflect a suboptimal
sequence of the GBV-B molecular clone atthisposition,andunlikely
to be a specific compensatory response to the inclusion of HCV
sequence within the chimeric 59NTR. Taken together, the data thus
indicate that the C9052Ua n dC 9065U substitutions in the 39NTR are
clearlycompensatoryandspecificallyrelatedtothepresenceofHCV
sequence in the 59NTR, while no other nucleotide change was
subsequently found to confer increased fitness specifically to the
59NTR chimeric virus.
Effect of in vivo compensatory mutations on 59NTR
chimeric RNA translation and replication
To explore the mechanism(s) underlying the compensatory
effect of these mutations on the in vivo replication fitness of the
chimeric virus, we investigated whether these mutations enhance
the translation and/or replication fitness of the corresponding
chimeric RNA replicons. We first focused on the two substitutions
in the 39NTR, which were introduced into the cDNA of the
chimeric replicon GBneoD/III
HC, as well as that of the parental
GBV-B replicon neo-RepD, as a control (giving rise to GBneoD/
III
HCm39 and neo-RepDm39, respectively, Fig. 5A). In addition,
in order to evaluate the potential contribution of the 39NTR
region located upstream of the poly(U) sequence to genome
replication, we introduced a deletion of 27 nucleotides, extending
from the polyprotein stop codon to the poly(U) sequence, into both
GBneoD/III
HC and neo-RepD cDNAs (giving rise to GBneoD/
III
HCD39 and neo-RepDD39, respectively, Fig. 5A). Similar F-Luc
replicons were constructed and transfected into cB76.1/Huh7
cells, in order to determine whether these 39NTR mutations or the
39NTR deletion modulated viral RNA translation in cell culture.
As shown in Table 2, luciferase activities measured 4 hours after
transfection were similar for all these replicons, suggesting that
there is likely no contribution of the 39NTR domain upstream of
the poly(U) sequence to GBV-B RNA translation.
Next,replicationactivitiesofthese39NTRmutatedrepliconswere
compared by monitoring colony forming activities in transfected
cB76.1/Huh7 cells. The deletion of the 27 39NTR nucleotides
between the polyprotein stop codon and poly(U) sequence strongly
affected GBV-B replication, with ,20-fold and ,150-fold reduc-
tions in colony formation for neo-RepDD39 and GBneoD/III
HCD39
replicons, respectively, compared to their parental neo-RepD and
chimeric GBneoD/III
HC replicon counterparts (Fig. 5B).These data
suggest that the 39NTR segment upstream of the poly(U) stretch
contributes substantially to genome replication, but is not essential.
The deletion of this 39NTR segment appeared more deletorious in
the context of the domain III chimeric replicon than in the parental
GBV-B backbone, but the significance of this is uncertain.
Importantly, and in strong contrast to what we found with the full-
length RNA constructs in tamarins, the two 39NTR mutations had
no effect on the replication competence of either the parental or
chimeric subgenomic GBV-B replicon RNAs (compare neo-
RepDm39 and neo-RepD, as well as GBneoD/III
HCm39 and
GBneoD/III
HC, Fig. 5B). We sequenced GBneoD/III
HCm39 RNA
presentina poolofcellclonesharvested at 3 weekspost-transfection,
and demonstrated that these RNAs retained the chimeric 59NTR
Table 1. Summary of the infectivity of mutated chimeric GB/III
HC genomes in vivo and sequencing of corresponding viruses
Tamarins E1
a p13
a NS5A
a NS5B
a 39NTR
a Infectivity
b Virus mutations
c
T16453 G1012AU 2376CU 7152CA 7945GC 9052U/C9065U + DC238,G 5225A
T16452 — U2376CU 7152C— C 9052U/C9065U + G5225A
T16448 — — U7152C— — 2 NA
T16468 — — U7152C— — 2 NA
T16457 — — — — C9052U/C9065U +/2 NA
T16463 — — — — C9052U/C9065U +/2 NA
T16459 — — U7152C— C 9052U/C9065U + —
T16440 — — U7152C— C 9052U/C9065U + DC238,C 5226U
aCombinations of nucleotide substitutions introduced into chimeric genome GB/III
HC in the indicated genomic regions (—: no substitution). Numbering refers to
nucleotide position within genome-length GBV-B RNA. Substitutions U2376Ca n dU 7152C lead to amino acid changes Ile644Thr and Val2236Ala, respectively.
bThe infectivity of mutated chimeric RNAs was assessed by intrahepatic inoculation of corresponding synthetic RNAs into 1 or 2 tamarins and was scored ‘‘+’’ when
viremia developed according to wild-type-like profile and peak viremia was $3.5610
7 ge/mL, ‘‘+/2’’ when viremia was sporadic and #2.5610
4 ge/mL, and ‘‘2’’ when
viremia remained negative or #1.5610
3 ge/mL at 1–2 scattered time points.
cMutations additionally found in the corresponding chimeric viruses rescued in vivo (numbering in the 59NTR refers to nucleotide position within the chimeric GBV-B/
HCV 59NTR). Substitutions G5225Aa n dC 5226U lead to amino acid changes Ala1594Thr and Ala1594Val, respectively. —: no mutation was found in the sequenced regions.
NA: not applicable, either because there was no virus rescued or because the viral titers were too low to proceed to sequencing.
doi:10.1371/journal.pone.0004419.t001
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Thus, these studies revealed that the two mutations at nucleotides
9052 and 9065 in the 39NTR segment upstream of the poly(U)
sequence do not modulate the replication efficiency of the chimeric
GB/III
HC RNA in cell culture.
The U7152C mutation resulting in a Val2236Ala change in NS5A
that we identified in the vGB/III
HC genome is naturally present in
the neo-RepD and GBneoD/III
HC replicon cDNAs, as these were
constructed from different infectious molecular clones. Indeed, the
molecular clone from which neo-RepD is derived differs from the
molecular clone used in our in vivo studies by 38 nucleotides
scattered throughout the genome, with the exception of the
59NTR and 39NTR segment upstream of the poly(U) sequence.
We introduced a C7152U mutation in neo-RepD to match the
sequence of our GBV-B infectious clone at this position, and found
that this substitution had no effect on replicon colony forming
efficiency (data not shown). This result argues that this substitution
within the NS5A coding sequence is likely not to act at the level of
genome replication.
Altogether, these data suggest that the cooperative effect of the
NS5Aand 39NTR mutationson thereplication fitness of the 59NTR
chimeric virus is likely to act at a step in the virus life cycle that is
subsequent to viral RNA translation and genome replication.
Discussion
GBV-B is the only other tentative member of the hepacivirus
genus, along with HCV, and a model virus that can be used in vivo
in small primates to mimic certain aspects of HCV infection. In
this study, a GBV-B subgenomic replicon allowed the identifica-
Figure 4. In vivo infectivity of mutated chimeric RNAs. Synthetic, genome-length RNA transcripts derived from (A) the parental GBV-B
infectious molecular clone [5] or (B–F) 59NTR domain III chimeras containing all or combinations of the 6 nucleotide substitution(s) found in the
chimeric virus rescued in vivo, were inoculated individually into the liver of GBV-B-naı ¨ve tamarins (B, C, and right graphs in panels D–F) or tamarins
that previously received nonreplicating GBV-B-derived RNAs (A and left graphs in panels D–F). Nucleotide substitutions (see Table 1) are depicted by
open arrows (silent changes) or filled arrows (coding changes or changes in the 39NTR) under the schematic genome inserted above each graph (B–
F). The extent of viremia (shaded area) was monitored over time in the serum of each animal by quantitative (q)-RT-PCR (genome equivalents, (ge)/
mL), as well as by analysis of alanine aminotransferase (ALT) activity (black dots, international units, IU). ALT baseline levels are indicated on each
graph by a dotted line.
doi:10.1371/journal.pone.0004419.g004
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PLoS ONE | www.plosone.org 8 February 2009 | Volume 4 | Issue 2 | e4419Figure 5. Replication activities of replicons with mutated 39NTR. (A) The chimeric or mutated nature of the 59 and 39 NTRs of the indicated
chimeras is depicted on the left and right of the figure, respectively, below the GBV-B subgenomic replicon scheme (see legend to Fig. 1). In the
59NTRs, white and black boxes correspond to GBV-B and HCV sequences, respectively. Within the 39NTR of GBV-B, dark grey boxes correspond to the
poly(U) tract, stars to the indicated nucleotide substitutions (numbering refers to nucleotide positions within GBV-B genome-length cDNA), and
broken lines to the extent of the nucleotide deletion. Positions of translation initiator (AUG) and termination (UGA) codons are indicated by arrows.
(B) G418-resistant colony forming activities of the indicated RNAs with a GBV-B 59NTR (grey bars) or a chimeric 59NTR containing HCV domain III
(black bars) are expressed as means6SD of log values obtained in $4 independent transfections (2610
6 cells transfected with 5 mg RNA) performed
with $3 independent RNA transcript syntheses, relatively to that of neo-RepD set at the mean value6SD obtained throughout transfection
experiments. Typical patterns of G418-resistant cell clones stained at 3 weeks post-transfection from 100-mm dishes in which 5610
5 transfected cells
were plated are shown above the graph for each replicon.
doi:10.1371/journal.pone.0004419.g005
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replication. This replicon (neo-RepD) [30] is derived from an
infectious molecular clone that induces a robust viremia upon
inoculation of synthetic RNAs in the liver of tamarins [33]. While
GBV-B infects small New World primates like tamarins,
marmosets and owl monkeys, but not chimpanzees [34], hence
probably not humans either, neo-RepD replicon RNA is adapted
to replicate in human hepatoma, Huh7-derived cells [30].
We found no significant differences in the translational activities
of replicon RNAs containing chimeric HCV/GBV-B sequences
engineered within the backbone of GBV-B subgenomic replicon
(Fig. 1), either in rabbit reticulocyte lysates (Fig. 2A) or in cell
culture (Fig. 2B), regardless of whether translation was driven from
a chimeric GBV-B/HCV IRES (II
GB/III
HC/IV
GB or II-III
HC/
IV
GB), or intact HCV or GBV-B (II-III-IV) IRESs. Also, we
observed no differences in translational activity when domains II-
III of both GBV-B and HCV were fused to each other with an
intervening spacer sequence (GBneoD-I-III
GB/II-IV
HC), despite
the potential for competition for essential translational factors.
However, it should be noted that there was a minor but significant
enhancing effect on translation when domain IV was derived from
the same virus as the sequence in domains II-III of the IRES
(GBneoD-I-II
GB/II-IV
HC versus GBneoD-I-II
GB/II-III
HC, Fig. 2).
Conflicting data have been reported in the literature with respect
to the putative role of the 39NTR on the regulation of HCV RNA
translation, ranging from no effect [28,35,36], to a stimulatory
effect [37] or inhibitory effect [38]. A recent study suggested that
these conflicting findings arose from the use of different viral RNA
systems, including reporter mini-genomes, dicistronic subgenomic
replicon RNAs, or full-length genomes [39]. Song et al. concluded
that, in the case of HCV, the three structural regions of the
39NTR including the variable region, the poly(U/C) tract and the
39-X region all contribute significantly to HCV IRES activity,
suggesting that a functional interaction between 59 and 39 NTRs is
involved in HCV RNA translation [39]. Our findings for GBV-B
show that the 39NTR segment upstream of the poly(U) tract does
not modulate GBV-B IRES activity in subgenomic parental or
chimeric GBV-B/HCV replicons (Table 2).
Structural predictions suggest that domain I of the GBV-B
59NTR folds into two stem-loops, whereas domain I of HCV
59NTR is shorter and is predicted to fold into a single 59 terminal
stem-loop [18,19]. A mutational study of an HCV subgenomic
replicon suggested that the 59-proximal stem-loop of the HCV
RNA is an essential cis-acting RNA element for HCV genome
replication [40]. We show here that domain I of GBV-B 59NTR is
also essential and provides virus-specific RNA replication elements
that cannot be substituted by the corresponding HCV proximal
stem-loop I. The present study also shows that domain II of the
GBV-B 59NTR is critical for RNA replication, in addition to its
known role in translation. The involvement of both domains I and
II in genome replication is shared by HCV, a feature that was
previously reported using HCV subgenomic replicons in which
translation of the first cistron was placed under the control of
poliovirus IRES [25,26]. Reusken et al. reached the same
conclusion by showing that subgenomic HCV RNAs failed to
replicate when domains II or II-III were replaced by the
corresponding domain(s) from a pestivirus 59NTR [27].
Domains III of GBV-B and HCV exhibit only ,60%
nucleotide identity, but do share similar lengths and structural
folds [19] and were shown here to be exchangeable with minimal
loss of GBV-B replicon colony formation (Fig. 3). In addition, we
did not observe enhancement in colony formation with a chimeric
replicon in which GBV-B domains I through III were present
upstream of the HCV IRES (GBneoD-I-III
GB/II-IV
HC), as
compared to the chimeric replicon in which only domains I-II of
GBV-B were present upstream of the HCV IRES (GBneoD-I-
II
GB/II-IV
HC) (Fig. 3), while all of these replicons had similar
translational activities (Fig. 2). In contrast, the addition of domain
III to domains I-II of HCV 59NTR upstream of the poliovirus
IRES in HCV subgenomic replicons increases by 100-fold HCV
replicon colony formation in Huh7 cells [25,26]. Thus, while both
GBV-B and HCV contain replication signals that overlap
translation signals in domain II, 59NTR sequences involved in
RNA replication of GBV-B do not appear to extend into domain
III, in contrast to that of HCV. Our data suggest, however, that
GBV-B domainIII might be involved inregulating a switchbetween
translation and replication when both activities are coupled, since a
chimeric II
GB-III
HC segment ensuring both translation and
replication (in GBneoD/III
HC) provides parental-type translational
activity, but not full replication capacity. Alternatively, we cannot
rule out the possibility that the presence of the HCV domain III
might modify the folding of the GBV-B domain II in this chimeric
construct, therebypotentially affecting important GBV-Breplication
signals. However, M-FOLD-assisted structural modeling of the
GBneoD/III
HC 59NTR did not suggest that there are changes in the
folding of domain II in this chimeric 59NTR (not shown). Despite
thesedifferencesbetweenGBV-B andHCV domainIIIrequirement
for genome replication, 59NTR sequences involved in genome
replication of these hepaciviruses in cell culture both differ strikingly
fromthoseinpestiviruses,forwhichonlythemost59fournucleotides
appear essential for RNA replication, and only domain I is required
for efficient replication [41–43].
We also investigated the role of the 39NTR segment upstream of
the poly(U) stretch in GBV-B genome replication. In HCV, the
deletion of the proximal 23–24 nucleotides of the variable domain
upstream of the poly(U/C) segment in the 39NTR did not hamper
genome infectivity in vivo, in chimpanzees [44], but impaired
subgenomic RNA replication [29]. Interestingly, a genome-length
GBV-B RNA bearing a 27 nucleotide-deletion from stop codon to
poly(U) sequence was readily infectious in tamarins [6], while we
show here that the GBV-B subgenomic replicon bearing a similar
deletion (neo-RepDD39) exhibits a significantly reduced (,20-fold)
colony formation activity (Fig. 5B). Although GBV-B genome-
length RNAs and subgenomic replicons were not derived from
Table 2. Translational activities of 39NTR mutant replicons in
cB76.1/Huh7 cells
Replicon
a Relative F-Luc activity (%)
b
Luc-RepDm39 107641
Luc-RepDD39 129647
GBLucD/III
HC 102632
GBLucD/III
HCm39 175620
GBLucD/III
HCD39 127666
Luc-RepDDIII 0.2460.07
LucD-GAA 13165
aReplicon RNAs containing 39NTR mutations or deletions correspond to those
depicted in Fig. 5A, but encode firefly luciferase (F-Luc) in place of neomycine
phosphotransferase. Luc-RepDDIII and LucD-GAA control RNAs are described
in the legend of Fig. 2.
bF-Luc RLU activities were determined 4 hours after transfection of equal
amounts (5 mg) of replicon RNAs into cB76.1/Huh7 cells, and expressed
relatively to Luc-RepD set at 100% after normalization with respect to total
protein quantities assayed (mean6SD from two independent transfections,
each monitored in duplicate wells).
doi:10.1371/journal.pone.0004419.t002
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in colony formation activity, as observed here for subgenomic
domain III chimeric RNA GBneoD/III
HC, could account for the
lengthy delay in replication of the corresponding genome-length
chimeric RNA in vivo in tamarins [3]. In line with this, while we
showed that 3 nucleotide substitutions in NS5A coding sequence
and 39NTR were necessary and sufficient for adaptation of the
genome-length domain III chimera to efficient replication in
tamarins (Fig. 4, Table 1), we did not find these mutations to
enhance genome translation or replication in the replicon model
(Table 2, Fig. 5B). Altogether, assuming that Huh7-derived cells
and tamarin hepatocytes provide similar cellular factors involved
in GBV-B genome replication, our data suggest that these adaptive
mutations may act to facilitate a later step in the virus life cycle,
possibly involving packaging and/or particle assembly.
The involvement of both 39NTR sequences and NS5A protein in
hepacivirus assembly is not unprecedented. Studies using the JFH1
strain of HCV in cell culture [45,46] indicate that the C-terminal
domain III of NS5A is essential for assembly of infectious particles.
The mechanisms of action of NS5A in particle assembly are not fully
understood yet, but they appear to involve the ability of NS5A to co-
localize together with the core protein on lipid droplets, a cellular
organelle that was recently discovered to play a key role in HCV
particle assembly [47]. Although the structure and function of GBV-
B NS5A have not yet been investigated, it is interesting to note that
the Val2236Ala substitution that we found in vGB/III
HC maps to the
C-terminus of GBV-B NS5A, in a region that aligns with domain III
of HCV NS5A. Packaging signals are not known for HCV or GBV-
B, but could well involve core protein/RNA interactions. A segment
of the conserved 39X domain of the HCV 39NTR has been
suggested to be involved in RNA dimerization in an interaction that
is chaperoned by the core protein [48,49]. The authors of these
studies found that the 39X segment was able to adopt several
alternative monomeric or dimeric conformations, and proposed that
interconversions between these various forms might constitute a
molecular switch that could regulate translation/replication/pack-
aging of the positive-strand viral RNA. Similarly, the GBV-B core
protein appears to have a chaperone activity that facilitates stable
RNA structures and 39NTR dimerization, although potential
39NTR domains involved in these structures have not been
described [50]. It is tempting to speculate that the 39NTR mutations
that we have shown here provide fitness to the chimeric vGB/III
HC
virus in tamarins do so by facilitating a cooperative interaction with
the chimeric 59NTR and possibly with the C-terminal region of
NS5A. Such an interaction could either regulate a molecular switch
shifting viral RNA from replication to packaging, or otherwise
facilitate infectious GBV-B particle assembly. An immortalized
primate hepatocyte cell line susceptible to GBV-B infection would
help address this potential mechanism, which may be common to all
hepaciviruses.
Materials and Methods
Cells
Human hepatoma cells cB76.1/Huh7 [17], derived from HuH-
7 cells [51], were cultured in Dulbecco’s modified Eagle’s medium
supplemented with 100 U of penicillin per mL, 100 mgo f
streptomycin per mL, and 10% fetal calf serum (DMEM-10%).
Plasmids
The GBV-B neo-RepD plasmid [30] contains a dicistronic
subgenomic GBV-B cDNA which encodes a fusion polypeptide
comprised of the 22 N-terminal amino acids of core fused to
neomycin phosphotransferase (neo) (which confers resistance to
G418) under the translational control of GBV-B IRES, and GBV-
B NS3-NS5B under the translational control of the EMCV IRES
(Fig. 1B). The replicon cDNA is inserted downstream of a unique
BamHI restriction site followed by the T7 RNA polymerase
promoter, and upstream of a unique SapI restriction site that
allows the production of an exact 39 terminus of the viral cDNA
for transcription purposes. A unique AscI restriction site is placed
between GBV-B core codons and the neo gene. A GDD-to-GAA-
mutated neo-RepB cDNA [neo-GAA, Ref. 17] was used as a
source of nonreplicative RNA in the experiments.
Chimeric segments from previously described plasmids pGB/I-II-
III
HC,p G B / I I - I I I
HC, and pGB/III
HC that contain genome-length
GBV-BcDNAwithchimericGBV-B/HCV59NTRs[3] werePCR-
amplified using a sense primer hybridizing upstream of the T7 RNA
polymerase promoter and an anti-sense primer hybridizing to the
appropriate GBV-B core codons followed by an engineered 39-
terminal AscI restriction site. PCR fragments were then digested with
BamHI and AscI and substituted to the corresponding fragment in
neo-RepD, yielding plasmids pGBneoD/I-II-III
HC, pGBneoD/II-
III
HC, and pGBneoD/III
HC. To construct plasmid pGBneoD-I-
II
GB/II-III
HC, overlapping PCR was used on neo-RepD or HCV 1a
H77 cDNA [31] templates to fuse GBV-B 59NTR domains I-II
(nucleotides1–236)tonucleotides21–43 fromHCV 59NTR domain
I (which fold as a non-based-paired RNA sequence, playing the role
of a spacer sequence, see Fig. 1A), followed by HCV 59NTR
domains II-III (nucleotides 44–330) and GBV-B domain IV and first
22 core codons (nucleotides 435–511). The PCR fragment was then
digested with BamHI and AscI and introduced into the neo-RepD
plasmid in place of the analogous segment. An overlapping PCR
fragment containing GBV-B domains I-II (nucleotides 1–236) fused
to HCV domains II-III-IV and first 12 core codons (nucleotides 21–
377) was generated with a 39 extension containing an engineered
AscI restriction site, then digested by BamHIa n dAscI and substituted
to the corresponding BamHI-AscI fragment into plasmid neo-RepD,
yielding pGBneoD-I-II
GB/II-IV
HC.S i m i l a r l y ,aBamHI/AscI-re-
stricted PCR fragment containing GBV-B domains I-II-III (nucle-
otides 1–434) fused to HCV domains II-III-IV and first 12 core
codons(nucleotides21–377)wasintroducedintoplasmidneo-RepD,
generating pGBneoD-I-III
GB/II-IV
HC (see Fig. 1).
Primer-based mutagenesis and overlapping PCR were used to
introduce substitutions C9052T and C9065T (numbering refers to
nucleotide position within GBV-B genome-length cDNA) into the
39NTR of neo-RepD and GBneoD/III
HC cDNAs. The resulting
PCR fragment was digested with BglII (GBV-B nucleotide 8629)
and XhoI (downstream of the 39 SapI site) and cloned within these
restriction sites into neo-RepD and pGBneoD/III
HC in place of
the corresponding fragments to generate pneo-RepDm39 and
pGBneoD/III
HCm39, respectively. An overlapping PCR was
performed to delete nucleotides 9041–9067 within the GBV-B
39NTR, downstream of the termination codon and upstream of
the poly(U) stretch. The deleted BglII-XhoI restriction fragment
was then introduced into neo-RepD and pGBneoD/III
HC
plasmids in place of the analogous segments to generate pneo-
RepDD39 and pGBneoD/III
HCD39, respectively.
To construct parental and chimeric reporter replicon cDNAs
encoding firefly luciferase (F-Luc) in place of neo, the F-Luc gene
was PCR-amplified with primers harboring AscI and PmeI5 9 and
39 extensions, respectively, and cloned between AscI and PmeI
(located immediately upstream of the EMCV IRES) restriction
sites of the corresponding neo replicon cDNAs.
Primer-based mutagenesis and overlapping PCR were used to
introduce point substitutions in genome-length, chimeric 59NTR
cDNA GB/III
HC [3] (see Fig. 4 and Table 1). Appropriate unique
restriction sites surrounding each targeted nucleotide residue were
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corresponding parental restriction fragments.
In vitro transcription
Subgenomic replicon and genome-length cDNAs were linear-
ized with SapI and XhoI, respectively, prior to in vitro transcription
using MEGAscript T7 Kit (Ambion) according to the manufacturer’s
instructions. For subgenomic replicons only, the DNA template
was removed by treatment with TURBO DNase (Ambion) and
RNAs were purified by phenol-chloroform extractions and
precipitated with ethanol. RNA quality and yields were estimated
by electrophoresis on nondenaturing agarose gels with respect to
known quantities of an RNA molecular weight marker (RNA
millenium Markers formamide, Ambion). RNAs were stored at 280uC.
In vitro translation reactions
In vitro transcribed RNAs (200 ng) were used to program
translation reactions in Flexi
TM rabbit reticulocyte lysates (Pro-
mega) in the presence of 6 mCi of [
35S]-methionine (GE
Healthcare), 125mM KCl and canine pancreatic microsomal
membranes (Promega). Ten-microliter reactions were incubated at
30uC for 4 h. One-tenth of each reaction was mixed with LDS
sample buffer and analyzed by electrophoresis on NuPAGE 4–12%
Bis-Tris gels in MOPS buffer (Invitrogen). Gels were then fixed and
dried, and translation products were quantitated by Phosphor-
Imager (STORM 820, Molecular Dynamics).
Transfection of cultured cells and extraction of viral RNA
cB76.1/Huh7 cells (2610
6 cells) were transfected by electropo-
ration (EasyjecT Plus, EquiBio) with 5 mgo fin vitro transcribed
RNA, as previously described [52]. Quality and quantity of the
transfected RNAs were double-checked on agarose gels on the
transfection day. Transfected cells were seeded in 100 mm-
diameter dishes at variable densities and, when applicable,
supplemented with cells transfected with the replication-deficient
RNA neo-GAA to reach a final density of 5610
5 cells per dish.
Twenty-four hours after electroporation, medium was replaced by
DMEM-10% containing 0.25 mg/ml of G418 (Invitrogen) and
changed thereafter twice a week. At 3 weeks post-transfection,
G418-resistant cells clones supporting viral RNA replication were
either stained with a 0.1% cristal violet solution or selected and
expanded under selective pressure. Total RNA was extracted from
cell clones grown to confluence in 100-mm dishes using TRIzol
reagent (Invitrogen) following the manufacturer’s instructions.
RNA pellets were dissolved in 30 ml of RNase-free water and RNA
yields were quantified by optical density measurements.
Quantitative RT-PCR analysis of viral RNA
Viral RNA present in G418-resistant cells were quantitated by
real-time, 59-exonuclease RT-PCR (TaqMan) using 50 ng of total
RNA and a one-step procedure based on the one-Step RT-PCR
Master Mix Reagent kit (Applied Biosystems) and primers and probe
specific for GBV-B NS5A coding sequence, as previously
described [5]. RT was performed at 48uC for 30 min, followed
by an incubation at 95uC for 10 min and 40 cycles each comprised
of 15 s at 95uC and 1 min at 60uC. An in vitro transcribed
subgenomic GBV-B RNA, quantitated by optical density mea-
surement, was used as a standard. Products were analyzed on an
ABI PRISM
TM7700 Sequence Detector (Applied Biosystems).
Northern blot analysis
Total RNAs (7.5 mg) isolated from G418-resistant cells clones
were separated by electrophoresis on denaturating agarose-
formaldehyde gels and transferred overnight by capillarity to
nylon membranes (Hybond-N+, GE Healthcare) in SSC 106buffer.
RNAs were immobilized on membranes by UV-cross-linking
(700 mJ/cm
2). Membranes were then prehybridized for 1 h at
65uC in SSC 56 buffer containing 50% formamide, 0.5% SDS
and Denhardt 56, then hybridized overnight at 65uC in the same
buffer supplemented with an a-[
32P]-labeled antisense riboprobe
specific for the GBV-B NS5B coding sequence. A b-actin-specific
antisense riboprobe was used to normalize total RNA amounts
loaded on the gel. Membranes were then washed 3 times at room
temperature in SSC 26, SDS 0.1%, then 3 times at 74uC in SSC
0.16, SDS 0.1%. Specific RNAs were visualized by Phosphor-
Imager (STORM 820, Molecular Dynamics).
Luciferase assays
cB76.1/Huh7 cells (2610
6 cells) were transfected as described
above with 5 mgo fin vitro transcribed F-Luc replicon RNAs.
Fractions of the transfected cells (8610
4 cells) were seeded in
duplicates in 24-well plates. Four hours after transfection, cells
were washed with PBS and lyzed with 125 mlo fReporter Lysis Buffer
(Promega). Ten ml of cleared lysates were mixed with 50 mlo f
Luciferase Assay Reagent (Promega) and luciferase activity was
immediatly measured for 10 s in a luminometer (Lumat LB
9507, Berthold Technologies). For normalization purposes, total
protein contents of the lysates were determined by using the Micro
BCA
TM Protein Assay Kit (Pierce).
Infectivity assay in tamarins; Ethics statement
Tamarins (Saguinus mystax) were housed at the Southwest National
Primate Center at the Southwest Foundation for Biomedical
Research (San Antonio, Texas) and cared for in accordance with
the Guide for the Care and Use of Laboratory Animals.E x p e r i m e n t a l
protocols were approved by the Institutional Animal Care and Use
Committee of the Southwest Foundation for Biomedical Research.
The Southwest Foundation has full accreditation from Association
for Assessment and Accreditation of Laboratory Animal Care
Internationalandconductsresearchincompliancewithnationaland
international standards. Individual animals each received an
intrahepatic inoculation of RNA transcripts from a single genome-
length construct, to assess their infectivity. The liver was exposed by
a limited abdominal incision and approximately 100 mgo fR N A
inoculated directly into the liver. The quality of the RNA dilution
inoculated intrahepatically was subseqeuntly re-checked on a non-
denaturing agarose gel on the day of the inoculation. At 7–14 day
intervals p.i., serum was collected and assayed for alanine
aminotransferase (ALT) activity and viral RNA levels. For the latter,
RNA was isolated using a QiaAmp viral RNA extraction kit
(Qiagen) and quantitated by real-time, 59 exonuclease RT-PCR
(TaqMan) using a one-step procedure with the TaqMan EZ core
reagent kit (Applied Bisosystem) and primers located within the
GBV-B NS5A sequence, as described above.
Sequence analysis of viral RNAs
Viral RNAs extracted from G418-resistant cell clones or from
tamarin sera were reverse transcribed using an anti-sense primer
specific for nucleotides 9363–9379 in the GBV-B 39NTR or
random hexamer oligonucleotides and Superscript II reverse
transcriptase (Invitrogen). Purified cDNAs were PCR-amplified
using Platinum Taq DNA polymerase (Invitrogen) or pfu DNA
polymerase (Stratagene) and several primer pairs designed to span
the GBV-B subgenomic replicon sequence and generate ,1000–
2000 bp-long PCR fragments. Reactions were set up for 35 cycles
at 94uC for 30 s, 55uC for 30 s, 70uC for 1 min. Sequencing
reactions were programmed with uncloned PCR fragments using
GBV-B Replication Elements
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on ABI 3700 capillary or 373XL DNA sequencers (Applied
Biosystems).
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